Pfizer is looking to purchase Encysive to bolster is high blood pressure product portfolio.
*Group discounts available on request
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.
Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.
Hires and promotions for manufacturers, regulatory and agencies
The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.